Home > Healthcare > Medical Devices > Diagnostic Devices > Self-testing Market

Self-testing Market Analysis

  • Report ID: GMI7669
  • Published Date: Dec 2023
  • Report Format: PDF

Self-testing Market Analysis

The market by product type is segmented into kits, devices, and strips. The kits segment is further divided into self-testing kits, and self-collection kits. The kits segment accounted for majority revenue share and was valued at around USD 6.4 billion revenue in 2023.
 

  • Kits are designed to be user-friendly, with clear instructions and all components neatly organized. This simplicity appeals to consumers who may not be familiar with the technical aspects of individual devices and strips.
     
  • Self-testing kits can cater to a wide range of tests and health parameters within a single product. This versatility allows consumers to address different health concerns with a single purchase.
     
  • Consumers may perceive self-testing kits as offering better value for money compared to purchasing individual devices and strips separately.
     
Self-testing Market Share, By Sample Type (2023)

Based on sample type, the self-testing market is categorized into blood, urine, saliva, and other sample types. The blood segment held leading market share in 2023 and is anticipated to record significant growth rate to reach around USD 11 billion in 2032.
 

  • Blood-based tests provide insights into various health indicators, contributing to proactive health management. Blood-based self-testing allows for the early detection of potential health issues, promoting a proactive approach to well-being.
     
  • Individuals with chronic conditions, such as diabetes or cardiovascular diseases, often require regular monitoring of blood parameters. Blood sample-based self-testing kits offer a convenient way for these individuals to manage their health at home. Moreover, blood sample-based kits cater to a broad range of tests, including lipid profiles, glucose levels, and various biomarkers.
     
  • The COVID-19 pandemic has highlighted the importance of blood-based testing for infectious diseases. Home-based blood antibody tests became popular for assessing prior exposure to the virus.
     

The self-testing market by usage is categorized into disposable, and reusable. The disposable segment accounted for larger share and was valued at over USD 12.6 billion revenue in 2023.
 

  • Disposable kits are often designed for simplicity and ease of use. Users can perform the test without the need for complex preparation or cleaning procedures, making them more convenient for at-home testing.
     
  • The use of disposable components minimizes the risk of cross-contamination between different tests or users. This is essential for maintaining the accuracy and reliability of test results.
     
  • The increased awareness of infection control during the COVID-19 pandemic has boosted the demand for disposable self-testing kits, especially for at-home testing and point-of-care settings.
     

Based on application, the self-testing market is divided into blood glucose test, pregnancy test, allergy test, STD /STI test, cancer test, drug abuse testing, genetic testing, cholesterol and triglycerides tests, urinary tract infection testing, other applications. The allergy test segment held significant revenue share and was valued at around USD 6.3 billion in 2032.
 

  • Allergies, including food allergies, environmental allergies, and sensitivities, are on the rise globally. This increase in allergic conditions has led to a greater demand for self-testing options. For instance, self-testing kits that focus on food sensitivities, including common ingredients such as gluten or dairy, are particularly popular. Individuals with suspected food sensitivities use these kits to explore dietary adjustments.
     
  • Growing awareness of allergen sensitivity and its impact on overall health has contributed to the demand for self-testing kits. Individuals are more likely to seek ways to identify and manage allergens affecting their well-being.
     

The self-testing market by test type is categorized into laboratory tests and home-based tests. The home-based tests segment accounted for majority share and was valued at over USD 13.1 billion revenue in 2023.
 

  • Some individuals prefer the privacy of home-based testing, avoiding potential discomfort or embarrassment associated with laboratory-based testing. This is particularly relevant for tests related to sensitive health conditions.
     
  • For conditions that require frequent monitoring, such as blood glucose levels or fertility tracking, home-based testing kits provide a practical solution. Users can integrate testing into their daily routines.
     
  • Advances in technology have enabled the development of home-based testing kits for a wide range of health parameters, including infectious diseases, genetic testing, wellness markers, and more. This broad range of available tests contributes to increased demand.
     

Based on distribution channel, the self-testing market by is segmented into brick-and-mortar stores, and ecommerce. The brick-and-mortar stores segment accounted for majority revenue share and was valued at around USD 10 billion revenue in 2023.
 

  • Physical retail locations offer the opportunity for self-testing kits to be prominently displayed and promoted. Some consumers prefer the immediate gratification of purchasing self-testing kits in-store. They can obtain the product instantly without waiting for shipping, making it suitable for those who want quick access to testing solutions.
     
  • Additionally, in-store staff can provide face-to-face assistance and information about self-testing kits, addressing consumer questions and concerns. This personalized interaction contributes to consumer education and promotes product understanding.
     
North America Self-testing Market Size, 2020- 2032 (USD Billion)

North America self-testing market accounted for USD 4.8 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

  • The growing emphasis on consumer empowerment in healthcare has led individuals in North America to seek tools that enable them to actively participate in monitoring and managing their health. Self-testing kits provide a means for individuals to take control of certain aspects of their well-being.
     
  • Moreover, the prevalence of chronic diseases, including diabetes and cardiovascular conditions, in the region has contributed to the adoption of self-testing kits. These kits allow individuals to monitor specific health parameters regularly, facilitating proactive management of chronic conditions.
     
  • Furthermore, advances in technology, including the development of user-friendly devices, smartphone applications, and digital health platforms, have made self-testing more accessible and attractive to regional consumers.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Self-testing industry size was USD 15 billion in 2023 and is estimated to reach over USD 27.2 billion by 2032 due to the rise in chronic diseases and the rapidly aging population.

Self-testing industry size from the kits product type segment was valued at USD 6.4 billion in 2023 owing to their growing adoption to cater to a wide range of tests and health parameters.

North America self-testing industry size was USD 4.8 billion in 2023 and is predicted to witness substantial growth up to 2032 owing to the growing emphasis on consumer empowerment in healthcare.

Few of the major self-testing firms include F. Hoffmann-La Roche Ltd., Piramal Enterprises Ltd., Becton, Dickinson and Company, PRIMA Lab SA, B. Braun Melsungen AG, Alere Inc., Cardinal Health, and Quidel Corporation.

Self-testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 468
  • Countries covered: 22
  • Pages: 280
 Download Free Sample